RALPH H. ROUSELL, M.D.
To the editor: In the "Brief Reports" section of the July 1980 issue Berger and associate (1) reported the use of a portable syringe pump to deliver a slow subcutaneous injection of immune serum globulin at frequent intervals to maintain a satisfactory serum IgG level with little or no interference with patient activities. They suggested that patient compliance may be improved with subcutaneous infusion compared with painful intramuscular administration. Moveover, it seemed possible to deliver a larger dose by the subcutaneous than by the intramuscular route.
Very recently the Bureau of Biologics has issued a product license approval for the
ROUSELL RH. Immune Globulin for Intravenous Infusion. Ann Intern Med. ;96:124–125. doi: 10.7326/0003-4819-96-1-124_3
Download citation file:
Published: Ann Intern Med. 1982;96(1):124-125.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use